Abstract
Chronic hepatitis B (CHB) is a widespread disease associated with significant morbidity and mortality. At least 300 million people worldwide are chronically infected with the hepatitis B virus (HBV) with carrier rates as high as 20% in some populations (1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Davis GL: Chronic hepatitis. In: Kaplowitz N, ed. Liver and Biliary Diseases. Baltimore: Williams & Wilkins, 292–294, 1992
Korenman J, Baker B, Waggoner J, et al: Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Int Med 114: 629–634, 1991
Mutchnick MG, Appelman HD, Chung HT, et al: Thymosin treatment of chronic hepatitis B: A placebo-controlled pilot trial. Hepatology 14: 409–415, 1991
Mutchnick MG, Cummings GD, Hoofnagle JH, Shafritz DA: Thymosin: An innovative approach to the treatment of chronic hepatitis B. In: Goldstein AL, Garaci E, eds. Combination Therapies. Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases. New York: Plenum Publishing Corp., 149–156, 1992
Knodell RG, Ishak KG, Black WC, et al: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1: 431–435, 1981
Lieberman HM, LaBrecque DR, Kew MC, et al: Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers. Hepatology 3: 285–291, 1983
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mutchnick, M.G., Jaurequi, J.I., Shafritz, D.A. (1993). Sustained Response to Thymosin Therapy in Patients with Chronic Active Hepatitis B. In: Garaci, E., Goldstein, A.L. (eds) Combination Therapies 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2964-4_26
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2964-4_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6289-0
Online ISBN: 978-1-4615-2964-4
eBook Packages: Springer Book Archive